Journal of Hepatocellular Carcinoma
Volume 11, 2024 - Issue
Open access
180
Views
0
CrossRef citations to date
0
Altmetric
REVIEW
Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?
Vera HimmelsbachDepartment of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany
, Christine KochDepartment of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany
, Jörg TrojanDepartment of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, GermanyCorrespondence[email protected]
https://orcid.org/0000-0001-9414-378X
Fabian FinkelmeierDepartment of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany
https://orcid.org/0000-0001-8559-9910
Pages 363-372
|
Received 12 Oct 2023, Accepted 07 Feb 2024, Published online: 18 Feb 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.